Drug Profile
BEPO albumin
Latest Information Update: 28 Sep 2018
Price :
$50
*
At a glance
- Originator LG Life Sciences
- Developer LG Chem
- Class Albumins
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Anaemia
Most Recent Events
- 28 Sep 2018 No recent reports of development identified for phase-I development in Anaemia in World
- 28 Aug 2015 Phase-I clinical trials in Anaemia in World (unspecified route)